ERIS LIFESCIENCES
Back to Balance Sheet
|
ERIS LIFESCIENCES Last 5 Year Total Debt History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Debt | ₹2,310 Cr | ₹2,422 Cr | ₹2,735 Cr | ₹830 Cr | ₹45 Cr |
What is the latest Total Debt ratio of ERIS LIFESCIENCES ?
| Year | Total Debt |
|---|---|
| Mar2026 | ₹2,310 Cr |
| Mar2025 | ₹2,422 Cr |
| Mar2024 | ₹2,735 Cr |
| Mar2023 | ₹830 Cr |
| Mar2022 | ₹45 Cr |
How is Total Debt of ERIS LIFESCIENCES Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,310 Cr | -4.62 | |
| Mar2025 | ₹2,422 Cr | -11.47 | |
| Mar2024 | ₹2,735 Cr | 229.54 | |
| Mar2023 | ₹830 Cr | 1,744.03 | |
| Mar2022 | ₹45 Cr | - | |
Compare Total Debt of peers of ERIS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ERIS LIFESCIENCES | ₹17,678.0 Cr | -3% | -4.3% | -22.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,597.0 Cr | -0.1% | -2.4% | 13.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,195.0 Cr | 2.7% | 12.9% | 54.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,712.0 Cr | 1.8% | 2.5% | 40.9% | Stock Analytics | |
| CIPLA | ₹113,423.0 Cr | 0.6% | -3.8% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,195.0 Cr | 3.3% | 1.3% | -7.6% | Stock Analytics | |
ERIS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ERIS LIFESCIENCES | -3% |
-4.3% |
-22.7% |
| SENSEX | -1% |
-4.9% |
-11% |
You may also like the below Video Courses